New heart drug shows promise in chinese patients with thick heart muscle
Disease control
Completed
This study looked at the long-term safety of a drug called aficamten in 40 Chinese patients with a heart condition that makes the heart muscle too thick and blocks blood flow. Patients who had already been in a previous study took aficamten for up to several months. The main goal…
Phase: PHASE3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 10:26 UTC